http://crossborderbiotech.ca/2009/03/16/monday-deal-review-march-16-2009/ Biotechnology, Health and Business in Canada, the United States and Worldwide Mon, 02 Apr 2012 12:31:04 +0000 hourly 1 http://wordpress.com/ http://crossborderbiotech.ca/2009/03/16/monday-deal-review-march-16-2009/comment-page-1/#comment-563 Tue, 30 Jun 2009 02:22:10 +0000 http://crossborderbiotech.ca/?p=967#comment-563 [...] BioPharma Corp. (TSX, FSE: HBP), following its registration with the SEC in March, has commenced trading in the U.S. on the OTCQX International Market under the ticker symbol [...]

]]> http://crossborderbiotech.ca/2009/03/16/monday-deal-review-march-16-2009/comment-page-1/#comment-292 Tue, 21 Apr 2009 05:09:59 +0000 http://crossborderbiotech.ca/?p=967#comment-292 [...] of Advitech Inc. (TSXV: AVI) approved the private placement to AgeChem at Advitech’s annual [...]

]]> http://crossborderbiotech.ca/2009/03/16/monday-deal-review-march-16-2009/comment-page-1/#comment-262 Mon, 13 Apr 2009 22:12:05 +0000 http://crossborderbiotech.ca/?p=967#comment-262 [...]  LMS Medical Systems Inc. (TSX: LMZ) sold its software for electronic obstetrical records to an affiliate of McKesson Corporation, and entered into a services agreement that will generate fees through 2010 for proceeds plus service revenue of up to US$3 million.  LMS can continue to use, develop and distribute the software outside of the McKesson Clinical customer base.  LMS Medical’s listing is under review by the TSX, which was extended by 30 days on March 12. [...]

]]>